Search results
Results from the Health.Zone Content Network
The Access to COVID-19 Tools Accelerator (ACT Accelerator or ACT-A), or the Global Collaboration to Accelerate the Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed al-Jadaan on 24 April 2020.
COVID-19 vaccination mandates continue to change. Learn more about where the U.S. currently stands on requiring COVID-19 vaccines and tests.
For older adults who have been isolated from family and friends for the better part of a year to stay safe from the coronavirus, the emergency authorization of two COVID-19 vaccines offers some ...
Vaccines for COVID-19 not only lessen the risk of getting sick from the virus, but also of spreading it to others. But for some people, like young babies and people with weaker immune systems, the ...
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 , the virus that causes coronavirus disease 2019 . Prior to the COVID‑19 pandemic , an established body of knowledge existed about the structure and function of coronaviruses causing diseases like severe acute ...
The vaccine should slow the spread of COVID-19 around the world. Fewer people should get sick, and more lives can be saved. The Pfizer, Moderna, and Novavax vaccines have been shown to be at least ...
Healthy adults have the option of receiving any of the three COVID-19 vaccines. These are the: Pfizer mRNA vaccine. Moderna mRNA vaccine. Johnson & Johnson (J&J) adenoviral vector vaccine ...
The 2021 JAMA study of nearly 20,000 people who received a COVID-19 vaccine found adverse side effects were more commonly reported in mRNA vaccines like Moderna and Pfizer than in the non-mRNA ...